throbber
Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`www.elsevier.com/locate/ybbrc
`
`A structure–activity relationship study of siRNAs
`with structural variations
`
`Chan Il Chang a, Sun Woo Hong a, Soyoun Kim b, Dong-ki Lee a,*
`
`a Department of Chemistry and BK School of Molecular Science, Pohang University of Science and Technology, Pohang 790-784, Republic of Korea
`b Department of Chemistry, Dongguk University, Seoul 100-715, Republic of Korea
`
`Received 26 May 2007
`Available online 11 June 2007
`
`Abstract
`
`Specific knock-down of cellular gene expression using small interfering RNAs (siRNAs) is a powerful gene silencing technique in
`mammalian cells. Early siRNAs were double stranded, and 19–21 bp in length, but several variations in siRNA structure have been intro-
`duced to achieve better silencing efficiency. In addition, siRNA modules have been incorporated into higher-order RNA structures to
`generate multi-functional RNA molecules. The effects of such structural variations on the activities of siRNAs have not been thoroughly
`studied. Here, we present a structure–activity relationship study of siRNA structural variants. Specifically, we focus on the effect on
`silencing efficiency of the attachment of extra, target-unrelated sequences to the conventional short duplex siRNA structure. Interest-
`ingly, while some siRNA structural variants efficiently silence target gene expression, others show a reduction in or a complete lack
`of silencing activity. Off-target effects and innate immune responses triggered by siRNA structural variants were also measured. In vitro
`Dicer cleavage reactions show that all siRNA structural variants are substrates of Dicer, but digestion patterns vary. To our knowledge,
`this is the first systematic structure–activity relationship analysis of siRNAs bearing structural variations. Our results provide useful
`guidelines for the design of siRNA structural variants and for the construction of complex RNA molecules bearing functional siRNA
`modules.
`Ó 2007 Elsevier Inc. All rights reserved.
`
`Keywords: RNA interference (RNAi); Small interfering RNA (siRNA); Lamin; Structure–activity relationship; Off-target gene silencing; Innate immune
`response; OAS2; Dicer
`
`Small interfering RNAs (siRNAs) are double-stranded
`RNAs (dsRNAs) 19- to 21-bp in length that are able to tar-
`get and degrade cellular mRNAs with complementary
`nucleotide sequences [1]. siRNA, along with its close rela-
`tive, short hairpin RNA (shRNA), utilizes the naturally
`occurring RNA interference (RNAi) pathway [2]. Because
`of high efficiency and specificity, siRNA-based gene silenc-
`ing has become a powerful molecular tool in target valida-
`tion and a promising future therapeutic approach [3].
`Initially, siRNA was designed as 19-bp double-stranded
`RNA with 2-nt 30 overhangs (termed the 19+2 structure) to
`mimic the Dicer-cleaved product of a long dsRNA [1].
`
`* Corresponding author.
`E-mail address: dlee@postech.edu (D. Lee).
`
`0006-291X/$ - see front matter Ó 2007 Elsevier Inc. All rights reserved.
`doi:10.1016/j.bbrc.2007.06.004
`
`Since then, several variations in the siRNA structure have
`been introduced to achieve better silencing efficiency. The
`first example of structural variation in the canonical
`19+2 siRNA was the development of 27 bp-long siRNAs
`[4,5] and 29 bp-long shRNAs [6]. These longer RNA
`duplexes provided better silencing efficiency than did
`19+2 siRNAs. In addition, siRNA modules were imple-
`mented within a higher-order RNA structure to obtain
`multi-functional RNA molecules. McNamara et al.
`[7]
`recently developed an aptamer–siRNA fusion RNA mole-
`cule to achieve aptamer-driven cell type-specific delivery of
`siRNAs. In another study, pRNAs were developed. These
`were based on bacteriophage phi29 RNA sequence and
`included a number of functional RNA modules, including
`siRNA modules, producing multi-functional RNA nano-
`particles [8]. Also, siRNAs with extended sense strands
`
`Alnylam Exh. 1088
`
`

`

`998
`
`C.I. Chang et al. / Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`have been developed to facilitate quantification of cellular
`siRNA concentrations [9].
`Although many siRNA structural variants exist, to date
`no systematic structure–activity relationship analyses have
`been performed on siRNA structures deviating from the
`canonical 19+2 structure. This is especially true of siRNAs
`fused to sequences unrelated to target mRNAs. An under-
`standing of the effect of appending extra sequences to siR-
`NAs on silencing efficiency and specificity is important for
`designing structurally modified siRNAs with optimal gene
`silencing efficiency. Also, several studies have shown that
`short dsRNAs such as siRNAs can be recognized by sev-
`eral cellular dsRNA sensors [10–12] to elicit innate immune
`responses, resulting in the non-specific induction of inter-
`feron-regulated genes and inflammatory cytokines. An
`understanding of the potential of siRNA structural vari-
`ants to trigger non-specific innate immune responses is
`important in the design of functional RNA molecules with
`few side-effects.
`In the present study, we designed and synthesized a
`number of siRNA structural variants and studied their
`structure–activity relationships, focusing on silencing effi-
`ciency, off-target gene silencing, and the potential to trigger
`innate immune responses. Specifically, we measured the
`effect of appending extra target-unrelated sequences to
`the conventional short duplex siRNA structure. We also
`examined the cleavage patterns of these siRNAs by the
`recombinant Dicer protein in vitro.
`
`Materials and methods
`
`Cell culture and transfection. HeLa cells were cultured in Dulbecco’s
`modified Eagle’s medium (Hyclone) supplemented with 10% (v/v) fetal
`bovine serum, 100 U/ml penicillin, and 100 lg/ml streptomycin. Cells were
`plated 24 h before transfection at 50% confluence in complete medium
`without antibiotics, in 12-well plates. All transfection assays were per-
`formed using oligofectamine,
`following the manufacturer’s protocol
`(Invitrogen) at the indicated concentrations, and cells were harvested 24 h
`after transfection.
`siRNAs. Chemically synthesized RNAs were purchased from Bioneer
`and annealed according to the manufacturer’s protocol. The sense and
`antisense strands of siRNAs were:
`
`19+0
`
`19+2
`
`27+0
`
`30LAS
`
`50LAS
`
`50-UGUUCUUCUGGAAGUCCAG-30 (antisense)
`30-ACAAGAAGACCUUCAGGUC-50 (sense)
`
`50-UGUUCUUCUGGAAGUCCAGdTdT-30 (antisense)
`30-dTdTACAAGAAGACCUUCAGGUC-50 (sense)
`
`50-UGUUCUUCUGGAAGUCCAGUUCCUCCU-30
`(antisense)
`30-ACAAGAAGACCUUCAGGUCAAGGAGGA-50
`(sense)
`
`50-UGUUCUUCUGGAAGUCCAGCGCUCGCCCGG-30
`(antisense)
`30-ACAAGAAGACCUUCAGGUC-50 (sense)
`
`50-CCGGGCGAGCGUGUUCUUCUGGAAGUCCAG-30
`(antisense)
`30-ACAAGAAGACCUUCAGGUC-50 (sense)
`
`30LS
`
`50LS
`
`50-UGUUCUUCUGGAAGUCCAG-30 (antisense)
`30-GGCCCGCUCGCACAAGAAGACCUUCAGGUC-50
`(sense)
`
`50-UGUUCUUCUGGAAGUCCAG-30 (antisense)
`30-ACAAGAAGACCUUCAGGUCGCGAGCGGGCC-50
`(sense)
`
`30LS30LAS 50-UGUUCUUCUGGAAGUCCAGCGCUCGCCCGG-30
`(antisense)
`30-GGCCCGCUCGCACAAGAAGACCUUCAGGUC-50
`(sense)
`
`50LS50LAS 50-CCGGGCGAGCGUGUUCUUCUGGAAGUCCAG-30
`(antisense)
`30-ACAAGAAGACCUUCAGGUCGCGAGCGGGCC-50
`(sense)
`
`30LS50LAS 50-CCGGGCGAGCGUGUUCUUCUGGAAGUCCAG-30
`(antisense)
`30-GGCCCGCUCGCACAAGAAGACCUUCAGGUC-50
`(sense)
`
`50LS30LAS 50-UGUUCUUCUGGAAGUCCAGCGCUCGCCCGG-30
`(antisense)
`30-ACAAGAAGACCUUCAGGUCGCGAGCGGGCC-50
`(sense)
`
`Quantitative real-time PCR. Total RNA was extracted from cell lysates
`using the Tri-reagent kit (Ambion). One microgram of total RNA was
`used as a template for cDNA synthesis performed with the ImProm-IIä
`Reverse Transcription System (Promega), according to the manufacturer’s
`protocol. Aliquots (1/20) of the cDNA reactions were analyzed by
`quantitative real-time PCR on a Rotor-Gene 3000 PCR machine (Corbett
`Research) according to the manufacturer’s protocol. Gene-specific primers
`for GAPDH, lamin, and OAS2 genes were mixed separately with Power
`SYBR Green PCR Master Mix (Applied Biosystems) containing cDNAs
`to be analyzed. Samples were run in duplicate and data obtained were
`analyzed with Rotor-Gene6 software
`(Corbett Research). Primer
`sequences for each gene were:
`
`Lamin—forward
`Lamin—reverse
`
`GAPDH—forward
`GAPDH—reverse
`
`OAS2—forward
`OAS2—reverse
`
`50-CCGAGTCTGAAGAGGTGGTC-30
`50-AGGTCACCCTCCTTCTTGGT-30
`50-GAGTCAACGGATTTGGTCGT-30
`50-GACAAGCTTCCCGTTCTCAG-30
`50-TCAGAAGAGAAGCCAACGTGA-30
`50-CGGAGACAGCGAGGGTAAAT-30
`
`In vitro Dicer cleavage assay. One hundred picomoles each siRNA
`duplex was cleaved using the Turbo Dicer siRNA Generation Kit (Gen-
`lantis) for 8 h, according to the manufacturer’s protocol. The concentra-
`tions of Dicer used varied from 0.1 to 1 U, as indicated. A 2-ll aliquot of
`each reaction (20 pmol) was separated in a 15% (w/v) non-denaturing
`polyacrylamide
`gel,
`stained with EtBr
`and visualized by UV
`transillumination.
`
`Results and discussion
`
`Structure–activity relationships of siRNAs with single strand
`extensions on one strand
`
`We first synthesized an siRNA targeting lamin A/C
`mRNA as described by Elbashir et al. [1] (Fig. 1A and
`
`

`

`C.I. Chang et al. / Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`999
`
`A
`
`19+0
`
`19+2
`
`27+0
`
`3’LAS
`
`5’LAS
`
`3’LS
`AS 5’
`
`5’LS
`
`19+0 27+0 3’LAS 5’LAS 3’LS 5’LS
`
`B
`
`C
`
`1nM
`10nM
`100nM
`
`5'LS
`3'LS
`5'LAS
`3'LAS
`27+0
`19+2
`19+0
`0nM
`
`0
`
`20
`
`80
`60
`40
`lamin level
`
`100
`
`120
`
`Fig. 1. Structures and activities of siRNAs with single strand extensions on one strand. (A) Structure of control siRNAs and siRNAs with single strand
`extensions on one strand. Extended sequences are underlined. (B) Non-denaturing PAGE analysis of the siRNAs in (A). (C) Lamin gene silencing activity
`of siRNAs in (A). Lamin mRNA level was measured 24 h after transfection. Data were calculated as ratios of lamin mRNA level/GAPDH mRNA level.
`Transfection with oligofectamine alone (0 nM) was the control and the lamin/GAPDH ratio was set at 100%. All data in the graph show means ± SD
`values from three independent experiments.
`
`B). The conventional 19+2 siRNA was transfected into
`HeLa cells using oligofectamine. As expected, good silenc-
`ing efficiency was observed at all concentrations tested
`(Fig. 1C). siRNAs with a 19-bp duplex with blunt ends
`(19+0), and a 27-bp duplex with blunt ends (27+0), also
`showed effective gene silencing (Fig. 1A–C). We used these
`siRNAs as control siRNAs in comparisons with siRNA
`structural variants.
`To study the structure–activity relationship of siRNA
`structural variants, we first designed and synthesized lamin
`siRNA variants with 11-nt extensions of target-unrelated
`sequences at either the 30 or the 50 ends of the antisense
`or sense strands, to generate the 30LAS, 50LAS, 30LS,
`and 50LS structures (Fig. 1A and B). These siRNA struc-
`tural variants were transfected into HeLa cells, and the
`lamin gene silencing efficiency was measured at three con-
`centrations of the siRNAs (100, 10, and 1 nM) and com-
`pared with the gene silencing efficiency of control
`siRNAs (19+0, 19+2, and 27+0). At 100 and 10 nM con-
`centrations, all four variant siRNAs showed good silencing
`activity (Fig. 1C). However, at the lowest siRNA concen-
`tration (1 nM), the silencing activities of the 50LS and
`50LAS, and the 30LAS siRNAs, which contained sequence
`extensions at the 50 end of the sense strand, the 50 end of
`the antisense strand or the 30 end of the antisense strand,
`respectively (Fig. 1A), were somewhat reduced (40–50%
`silencing)
`compared with control
`siRNAs
`(60–70%
`
`silencing) (Fig. 1C). However, 30LS, which has a sequence
`extension at the 30 end of the sense strand (Fig. 1A),
`showed gene silencing efficiency (70% silencing) similar
`to that of the control siRNAs (Fig. 1C). Single strand
`extension of extra sequences unrelated to the target mRNA
`thus has different effects on the gene silencing activity of
`siRNAs, depending upon the position of extension.
`
`Structure–activity relationships of siRNAs with single strand
`extensions on both strands
`
`synthesized siRNAs with both strands
`Next, we
`extended in opposite directions, resulting in bidirectional
`single-strand extension structures (Fig. 2A and B). The
`30LS30LAS siRNA had extensions at the 30 end of both
`strands, while the 50LS50LAS siRNA had sequence exten-
`sions at the 50 end of both strands (Fig. 2A). We transfec-
`ted these variant siRNAs and measured their gene silencing
`efficiencies at different siRNA concentrations (Fig. 2C).
`Interestingly, the gene silencing efficiencies of the two var-
`iant siRNAs were dramatically different. We found that
`even at the highest concentration tested (100 nM), the
`silencing efficiency of 50LS50LAS was reduced (50%
`silencing), compared with control siRNAs. On the other
`hand, 30LS30LAS siRNA effectively silenced lamin gene
`expression at this concentration. At 1 nM concentration,
`the 50LS50LAS siRNA completely lost gene silencing
`
`

`

`1000
`
`C.I. Chang et al. / Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`A
`
`C
`
`3’LS + 3’LAS
`
`5’LS + 5’LAS
`
`5'LS 5'LAS
`
`3'LS 3'LAS
`
`27+0
`
`19+2
`
`19+0
`
`0nM
`
`B
`
`19+0 27+0
`
`3’LS 5’LS
`3’LAS 5’LAS
`
`1nM
`10nM
`100nM
`
`D
`
`5'LS 5'LAS
`
`3'LS 3'LAS
`
`19+0
`
`0
`
`2
`
`8
`6
`4
`OAS2 level
`
`10
`
`12
`
`0
`
`20
`
`80
`60
`40
`lamin level
`
`100
`
`120
`
`Fig. 2. Structures and activities of, and antiviral responses to, siRNAs with single strand extensions on both strands. (A) Structures of siRNAs with single
`strand extensions on both strands. Extended sequences are underlined. (B) Non-denaturing PAGE analysis of the siRNAs in (A). (C) Lamin gene silencing
`activity of the siRNAs in (A). See the legend of Fig. 1C for details. (D) Fold-induction of OAS2 mRNA levels by siRNAs (100 nM) with single strand
`extensions on both strands. Data were calculated as ratios of OAS2 mRNA level/GAPDH mRNA level. OAS2 induction by 19+0 siRNA was set at unity.
`All data in the graphs show means ± SD values from two independent experiments.
`
`activity (Fig. 2C) but 30LS30LAS siRNA still maintained
`some silencing activity, although silencing was somewhat
`lowered (40% silencing). The low silencing activity of
`the 50LS50LAS siRNA was not due to a non-specific gen-
`eral decrease in the mRNA level, which might have been
`triggered by a dsRNA-mediated antiviral response, because
`the GAPDH mRNA level was similar in different RNA
`samples (data not shown). These results again demonstrate
`that extensions of siRNA strands affect gene silencing dif-
`ferently, depending on the end to which the extra sequence
`is attached.
`
`Structure–activity relationships of siRNAs with double
`strand extensions
`
`We also tested the silencing efficiency of long duplex
`siRNAs generated by adding 11-bp duplexes of target-
`unrelated sequences to either end of the 19+0 lamin siRNA
`(Fig. 3A and B). The 50LS30LAS siRNA, in which the extra
`duplex sequence was appended to the 30 end of the anti-
`sense strand, showed silencing efficiency comparable to
`that of the control siRNAs at all concentrations tested
`(Fig. 3C). However, the 30LS50LAS structure, in which
`the extra duplex sequence was attached to the 50 antisense
`end, showed a different gene silencing profile. While the
`silencing efficiency of this siRNA at 100 nM concentration
`
`was similar to that of the control siRNAs, silencing effi-
`ciency was reduced at 10 nM, and was further reduced
`(20% silencing) at 1 nM (Fig. 3C). As with other siRNA
`structural variants studied, we thus observed strong posi-
`tion effects when extra double-strand sequences were
`appended to gene silencing siRNAs.
`
`Off-target gene silencing triggered by siRNA structural
`variants
`
`To test whether the attachment of extra, target-unre-
`lated sequence generates off-target gene silencing, that is,
`to trigger silencing of genes other than lamin A/C [13],
`we performed DNA microarray experiments using micro-
`arrays containing about 8000 human cDNAs [10]. We
`transfected HeLa cells individually with either 19+0 blunt
`siRNA as a control or siRNA structural variants such as
`30LS, 30LS30LAS, and 50LS30LAS siRNAs. Microarray
`analysis showed that when HeLa cells were transfected
`with 19+0 siRNA, only a few genes in addition to lamin
`A/C gene were down-regulated more than twofold (Supple-
`mentary Fig. 1). Similarly, when cells were transfected with
`each siRNA structural variants, only one or two genes
`other than lamin A/C gene were down-regulated more than
`twofold (Supplementary Fig. 1). Moreover, the fold reduc-
`tion of these down-regulated genes was only slightly more
`
`

`

`C.I. Chang et al. / Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`1001
`
`A
`3’LS + 5’LAS
`
`5’LS + 3’LAS
`
`C
`5'LS 3'LAS
`
`3'LS 5'LAS
`
`27+0
`
`19+2
`
`19+0
`
`0nM
`
`B
`
`19+0 27+0
`
`3’LS 5’LS
`5’LAS 3’LAS
`
`1nM
`10nM
`100nM
`
`0
`
`20
`
`40
`
`80
`60
`lamin level
`
`100
`
`120
`
`Fig. 3. Structures and activities of long duplex siRNAs. (A) Structures of long duplex siRNAs. Extended sequences are underlined. (B) Non-denaturing
`PAGE analysis of the siRNAs in (A). (C) Lamin gene silencing activity of siRNAs in (A). See the legend of Fig. 1C for details.
`
`than twofold. From these results, we conclude that the
`structural variation of siRNA by the attachment of extra
`target-unrelated sequences does not trigger off-target gene
`silencing.
`
`Innate immune responses triggered by siRNA structural
`variants
`
`Several dsRNA sensors exist in cells to detect foreign
`dsRNAs and to then elicit innate immune responses [14].
`OAS2 is one of the key genes located downstream of
`dsRNA-induced innate immune responses. The gene can
`be induced by long dsRNAs such as poly(I:C) [15]. We
`examined if any of the siRNA structural variants used in
`this work might significantly induce OAS2 gene expression.
`While the absolute level of OAS2 mRNA was somewhat
`variable from experiment to experiment, consistent with a
`previous report [15], we found that most of the siRNA
`variants we tested did not increase the OAS2 mRNA level
`when compared with the OAS2 mRNA level induced by
`19+0 control siRNA, as measured by quantitative real-
`time PCR (data not shown). Intriguingly, even 30-bp
`duplex siRNAs, such as 50LS30LAS and 30LS50LAS, did
`not induce OAS2 gene expression above the level induced
`by the control 19+0 siRNAs. On the other hand, at
`100 nM concentrations, siRNAs with single strand exten-
`sions on both strands, the 50LS50LAS and 30LS30LAS siR-
`NAs,
`induced OAS2 mRNA levels severalfold higher
`than that induced by 19+0 siRNA (Fig. 2D). The level of
`
`induction was much lower, however, than the OAS2 induc-
`tion seen with poly(I:C), and while poly(I:C) triggered non-
`specific reduction of the global mRNA level and cell death,
`the 50LS50LAS or 30LS30LAS siRNAs did not show any of
`these effects (data not shown). Also, at lower concentra-
`tions (10 or 1 nM), even 50LS50LAS and 30LS30LAS
`siRNAs did not trigger the induction of OAS2 mRNA
`level. These results suggest that the siRNA structural vari-
`ants used in this study do not trigger a strong dsRNA-med-
`iated antiviral innate immune response.
`Reynolds et al. [16] have shown that long (27 bp) siR-
`NAs could trigger induction of a number of genes involved
`in the antiviral innate immune response, in a cell type-spe-
`cific manner. It is to note that the HeLa cell line we have
`used in this study was identified as one of the cell lines
`which is insensitive to the treatment of long siRNAs [16].
`Therefore, the relative lack of innate immune response trig-
`gered by siRNA structural variants in our study is consis-
`tent with their observation. In fact,
`in our microarray
`data, none of the genes induced by the long siRNA in
`the study of Reynolds et al. [16] was significantly induced
`by siRNA variants tested, except a moderate increase
`(2.5-fold) in the IL-8 mRNA level by the 30LS siRNA
`(Supplementary Figs. 2 and 3).
`
`Dicer-mediated cleavage of siRNA structural variants
`
`Some of the siRNA structural variants we designed
`showed reduced or negligible silencing efficiencies. We
`
`

`

`1002
`
`C.I. Chang et al. / Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`wondered if defective gene silencing might be due to the
`inefficient recognition and cleavage of such siRNA struc-
`tural variants by Dicer. To test
`this, we performed
`in vitro Dicer-mediated cleavage reactions. First, each siR-
`NA variant was digested for 8 h with 1 U recombinant
`Dicer enzyme, and the cleavage products were analyzed
`by running a non-denaturing PAGE gel (Fig. 4A). Dicer
`cleaves dsRNA substrates
`to generate 19-
`to 21-bp
`duplexes [17]. As expected, the 27+0 duplex was cleaved
`by Dicer to generate products of a size similar to that of
`the 19+0 siRNA duplex (Fig. 4A). To our surprise,
`Dicer-mediated cleavage of the siRNA structural variants
`generated products of various electrophoretic mobilities
`(Fig. 4A), and most of the cleavage products migrated
`differently from the 19+0 duplex siRNA (Fig. 4A). While
`further characterization of each cleavage product
`is
`required, this result strongly suggests that Dicer-mediated
`cleavage of siRNA structural variants generates products
`whose structures are different from that of the 19-bp
`duplex.
`Each siRNA with a single strand extension on one
`strand showed a unique cleavage pattern (Fig. 4A). The
`cleavage product of 30LAS was similar in size to the
`19+0 siRNA and to the cleavage product of 27+0 siRNA.
`However, 30LS and 50LS yielded Dicer-mediated cleavage
`products of more rapid electrophoretic mobility than
`19+0 siRNA and 50LAS yielded the cleavage product of
`highest mobility (Fig. 4A and B). On the other hand, siR-
`NAs with single strand extensions at both strands, the
`30LS30LAS and 50LS50LAS siRNAs, produced cleavage
`products with slower electrophoretic mobilities than that
`of 19+0 siRNA (Fig. 4A and Supplementary Fig. 4A),
`and the cleavage patterns of the two siRNAs were different.
`The
`cleavage pattern of
`the
`long duplex siRNAs,
`30LS50LAS and 50LS30LAS, were also intriguing. While
`
`these two siRNAs share an identical structure (duplexes
`of 30 bp), and differ in only the site of appended extensions,
`they yielded Dicer-cleaved products of different sizes
`(Fig. 4A and Supplementary Fig. 4B). 30LS50LAS gave
`cleavage products migrating faster than 19+0, whereas
`50LS30LAS yielded species migrating slower than 19+0
`(Fig. 4A and Supplementary Fig. 4B). This result suggests
`that Dicer-mediated cleavage patterns may depend not
`only on the structures but also on the sequences of siRNAs.
`We then tested whether the efficiency of gene silencing
`by each siRNA variant correlated with the efficiency of
`cleavage by Dicer, by using varying concentrations of the
`Dicer enzyme (Fig. 4B and Supplementary Fig. 4). Within
`the range of Dicer concentrations used, we did not observe
`significant differences in cleavage efficiencies between siR-
`NA variants (Fig. 4B and Supplementary Fig. 4). From
`these results, we hypothesize that different gene silencing
`efficiencies shown by different siRNA variants may not
`be because of differences in efficiencies of Dicer-mediated
`cleavage, but rather because of unique patterns and/or
`sequences of cleaved products generated from each siRNA
`variant.
`Although there have been a number of studies regarding
`the effect of chemical modification on the activity of siR-
`NAs [3], there have been no reports to date on the effect
`of siRNA structural modification on silencing activity,
`off-target gene silencing, and cellular innate immune
`responses. To our knowledge, this study is the first system-
`atic analysis of structure–activity relationships of siRNAs
`with structural variations.
`Jiang et al. [9] designed an siRNA structural variant that
`had a single strand DNA extension at the 30 end of the
`sense strand. This variant siRNA structure was efficient
`in target gene silencing, and was utilized as a PCR primer
`to quantitatively analyze siRNA concentrations inside
`
`A
`
`19+0 27+0 3’LS 5’LS 3’LAS 5’LAS 19+0 27+0
`—
`—
`—
`—
`—
`—
`
`Dicer
`
`3’LS 5’LS 3’LS 5’LS
`5’LAS 3’LAS 3’LAS 5’LAS
`—
`—
`—
`—
`
`B
`
`19+0 27+0 3’LS 5’LS
`(Unit) : 0 1 1 0.3 0.1 0 1 0.3 0.1 0
`
`Dicer
`
`Fig. 4. In vitro cleavage of siRNAs by recombinant Dicer. siRNAs before and after treatment with Dicer were analyzed by 15% (w/v) non-denaturing
`PAGE. (A) Cleavage of siRNAs by 1 U Dicer enzyme for 8 h. (B) Cleavage of 30LS and 50LS siRNAs with various concentrations of Dicer enzyme.
`
`

`

`C.I. Chang et al. / Biochemical and Biophysical Research Communications 359 (2007) 997–1003
`
`1003
`
`cells. We point out that 30 sense strand extension was the
`only single strand extension modification in our study that
`did not affect siRNA gene silencing efficiency (Fig. 1C). In
`addition, McNamara et al. [7] attached aptamer sequences
`to the 50 end of siRNA sense strands, and observed gene
`silencing. While the site of single strand extension used in
`their experiment was not optimal, based on our data, they
`used very high concentrations of siRNA (400 nM) to
`observe silencing. Indeed, at 100 nM concentration, all
`four siRNAs with single strand extensions showed good
`silencing efficiency (Fig. 1C). At the high concentration
`of aptamer–siRNA complex, efficient gene silencing should
`therefore have been observed. We predict that aptamer
`fusion to the 30 end of the sense strand siRNA might work
`better in gene silencing, at lower concentrations of the
`RNA complex, provided that the site of aptamer attach-
`ment does not affect aptamer structure.
`In summary, our results provide three important rules
`for the design of modified siRNA structures. First, the 30
`end of the sense strand of an siRNA is the site of choice
`for a strand extension containing extra sequences to main-
`tain maximal gene silencing. Second, extensions of both
`strands of an siRNA should be 30, not 50, to maintain gene
`silencing activity. Finally, when duplex extension is
`designed, addition of extra duplex sequences to the 30
`end of the antisense strand of an siRNA is preferred over
`extension on the 50 end of the antisense strand, to minimize
`the loss of gene silencing efficiency. We believe our findings
`will provide useful guidelines in the design of siRNAs with
`novel structures or in the synthesis of complex RNA mol-
`ecules which harbor siRNA as one of several functional
`modules. Toward the comprehensive understanding of
`the action mechanism of siRNA structural variants, future
`studies will focus on the characterization of the Dicer
`cleavage products generated from each siRNA variants,
`and the cleavage efficiency of each siRNA by Dicer–TRBP
`complex [18].
`
`Acknowledgments
`
`D.-K.L. was supported by grants from the National
`R&D Program for Cancer Control, Ministry of Health
`and Welfare, Republic of Korea (Grant 0520200-2), the
`Basic Research Program of KOSEF (Grant R01-2005-
`000-10266-0), and the SRC/ERC program of MOST/KO-
`SEF (Grant R11-2000-070-080010). S.K. was supported
`by a National Research Laboratory grant from MOST/
`KOSEF.
`
`Appendix A. Supplementary data
`
`Supplementary data associated with this article can be
`found,
`in the online version, at doi:10.1016/j.bbrc.
`2007.06.004.
`
`References
`
`[1] S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, T.
`Tuschl, Duplexes of 21-nucleotide RNAs mediate RNA interference
`in cultured mammalian cells, Nature 411 (2001) 494–498.
`[2] G.J. Hannon, RNA interference, Nature 418 (2002) 244–251.
`[3] Y. Dorsett, T. Tuschl, siRNAs: applications in functional genomics
`and potential as therapeutics, Nat. Rev. Drug Discov. 3 (2004) 318–
`329.
`[4] D.H. Kim, M.A. Behlke, S.D. Rose, M.S. Chang, S. Choi, J.J. Rossi,
`Synthetic dsRNA Dicer substrates enhance RNAi potency and
`efficacy, Nat. Biotechnol. 23 (2005) 222–226.
`[5] S.D. Rose, D.H. Kim, M. Amarzguioui, J.D. Heidel, M.A. Colling-
`wood, M.E. Davis, J.J. Rossi, M.A. Behlke, Functional polarity is
`introduced by Dicer processing of short substrate RNAs, Nucleic
`Acids Res. 33 (2005) 4140–4156.
`[6] D. Siolas, C. Lerner, J. Burchard, W. Ge, P.S. Linsley, P.J. Paddison,
`G.J. Hannon, M.A. Cleary, Synthetic shRNAs as potent RNAi
`triggers, Nat. Biotechnol. 23 (2005) 227–231.
`[7] J.O. McNamara 2nd, E.R. Andrechek, Y. Wang, K.D. Viles, R.E.
`Rempel, E. Gilboa, B.A. Sullenger, P.H. Giangrande, Cell type-
`specific delivery of siRNAs with aptamer–siRNA chimeras, Nat.
`Biotechnol. 24 (2006) 1005–1015.
`[8] A. Khaled, S. Guo, F. Li, P. Guo, Controllable self-assembly of
`nanoparticles for specific delivery of multiple therapeutic molecules to
`cancer cells using RNA nanotechnology, Nano Lett. 5 (2005) 1797–
`1808.
`[9] M. Jiang, A.A. Arzumanov, M.J. Gait, J. Milner, A bi-functional
`siRNA construct induces RNA interference and also primes PCR
`amplification for its own quantification, Nucleic Acids Res. 33 (2005)
`e151.
`[10] J.W. Yoo, S.W. Hong, S. Kim, D.K. Lee, Inflammatory cytokine
`induction by siRNAs is cell type- and transfection reagent-specific,
`Biochem. Biophys. Res. Commun. 347 (2006) 1053–1058.
`[11] J.T. Marques, T. Devosse, D. Wang, M. Zamanian-Daryoush, P.
`Serbinowski, R. Hartmann, T. Fujita, M.A. Behlke, B.R. Williams, A
`structural basis for discriminating between self and nonself double-
`stranded RNAs in mammalian cells, Nat. Biotechnol. 24 (2006) 559–
`565.
`inflammatory cytokines and interferon
`[12] M. Sioud, Induction of
`responses by double-stranded and single-stranded siRNAs
`is
`sequence-dependent and requires endosomal
`localization, J. Mol.
`Biol. 348 (2005) 1079–1090.
`[13] A.L. Jackson, S.R. Bartz, J. Schelter, S.V. Kobayashi, J. Burchard,
`M. Mao, B. Li, G. Cavet, P.S. Linsley, Expression profiling reveals
`off-target gene regulation by RNAi, Nat. Biotechnol. 21 (2003) 635–
`637.
`[14] E. Meylan, J. Tschopp, Toll-like receptors and RNA helicases: two
`parallel ways to trigger antiviral responses, Mol. Cell 22 (2006) 561–
`569.
`[15] C. Dahlgren, C. Wahlestedt, H. Thonberg, No induction of anti-viral
`responses in human cell lines HeLa and MCF-7 when transfecting
`with siRNA or siLNA, Biochem. Biophys. Res. Commun. 341 (2006)
`1211–1217.
`[16] A. Reynolds, E.M. Anderson, A. Vermeulen, Y. Fedorov, K.
`Robinson, D. Leake, J. Karpilow, W.S. Marshall, A. Khvorova,
`Induction of the interferon response by siRNA is cell type- and
`duplex length-dependent, RNA 12 (2006) 988–993.
`[17] E. Bernstein, A.A. Caudy, S.M. Hammond, G.J. Hannon, Role for a
`bidentate ribonuclease in the initiation step of RNA interference,
`Nature 409 (2001) 363–366.
`[18] T.P. Chendrimada, R.I. Gregory, E. Kumaraswamy, J. Norman, N.
`Cooch, K. Nishikura, R. Shiekhattar, TRBP recruits the Dicer
`complex to Ago2 for microRNA processing and gene silencing,
`Nature 436 (2005) 740–744.
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket